Mount Sinai School of Medicine, Site #189 — New York, New York

Mount Sinai School of Medicine, Site #189 is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai School of Medicine, Site #189 has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia.

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai School of Medicine, Site #189?

Mount Sinai School of Medicine, Site #189 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai School of Medicine, Site #189 conducted?

Mount Sinai School of Medicine, Site #189 has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia.

Is Mount Sinai School of Medicine, Site #189 accredited by Crixeo Health?

Mount Sinai School of Medicine, Site #189 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai School of Medicine, Site #189?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.